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Nearly 85% of radiotherapy patients develop acute radiation dermatitis, which is an 
inflammatory reaction of the skin at the treatment field and in the surrounding area. The 
aims of this study were to unravel the mechanisms of radiation-induced inflammatory 
responses after localized irradiation in a human 3D organotypic skin culture model. 
This could provide possible inflammatory targets for reduction of skin side effects. 3D 
organotypic skin cultures were set up and locally irradiated with 225 kVp X-rays, using a 
combination of full exposure and partial shielding (50%) of the cultures. The secretion of 
pro-inflammatory cytokines, the phenotype, and the differentiation markers expression 
of the cultures were assessed up to 10  days postirradiation. The pro-inflammatory 
transcription factor nuclear factor kappa B (NF-κB) and cyclooxygenase-2 (COX-2) 
pathways have been studied. The results showed fast activation of NF-κB, most likely 
triggered by DNA damage in the irradiated cells, followed by upregulation of p38 MAPK 
and COX-2 in the irradiated and surrounding, non-irradiated, areas of the 3D cultures. 
The application of the COX-2 inhibitor sc-236 was effective at reducing the COX-2 
mRNA levels 4 h postirradiation. The same inhibitor also suppressed the PGE2 secretion 
significantly 72 h after the treatment. The expression of a pro-inflammatory phenotype 
and abnormal differentiation markers of the cultures were also reduced. However, the 
use of an NF-κB inhibitor (Bay 11-7085) did not have the predicted positive effect on the 
cultures phenotype postirradiation. Radiation-induced pro-inflammatory responses have 
been observed in the 3D skin model. The activated signaling pathways involved NF-κB 
transcription factor and its downstream target COX-2. Further experiments aiming to 
suppress the inflammatory response via specific inhibitors showed that COX-2 is a 
suitable target for reduction of the normal skin inflammatory responses at radiotherapy, 
while NF-κB inhibition had detrimental effects on the 3D skin model development.
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inTrODUcTiOn
The skin is one of the most important and dose-limiting organs 
that is inevitably included in the exposed field during conven-
tional radiotherapy. Due to the fast tissue turnover, the repair of 
radiation-induced DNA damage in the basal skin layer is often 
insufficient, which leads to high cell killing. Most affected are 
the hair follicle stem cells and melanocytes (1). After an initial 
decrease in cell number, there is an accelerated repopulation of 
the cells, which results in changes in the skin surface appearance 
(2). In addition, histamines are secreted and they induce a local 
pro-inflammatory response, the clinical result of which ranges 
from mild erythema to ulceration (2). After single doses, higher 
than 5 Gy, the skin reacts with an erythema-like response within a 
few hours including vasodilatation, edema, and leakage of plasma 
constituents from the capillaries. Erythema followed by dry and 
moist desquamation develops on second to third week after frac-
tionated irradiation due to depletion of the stem cell compart-
ment in the basal layer. Spreading out the dose over 6–8 weeks 
enables the skin to tolerate doses up to 60 Gy through stem cell 
repopulation (3, 4). After this period, the epidermis either heals 
or the changes progress to chronic wounds that might lead to 
necrosis (5). These effects develop at different levels during con-
ventional radiotherapy. Depending on the individual sensitivity 
of the patient, they could cause complications, delay in radiation 
treatment, and even the need of surgical intervention. The late 
chronic reactions are reported to be permanent and progressive 
without complete treatment (6). This widely affects the quality of 
life of breast cancer patients (7, 8). Although numerous oral and 
topical treatments have been suggested, there is no generalized 
and satisfactory treatment of radiation-induced skin reactions 
(8). One of the main reasons is that mechanistic studies of skin 
reactions that involve all the stages at cellular, functional, and 
systemic level have been limited.
Interestingly, many of the routinely used or novel chemotherapy 
compounds (e.g., doxorubicin, docetaxel, paclitaxel, methotrex-
ate, tamoxifen, etc.) have a synergistic effect on radiation-induced 
skin damage (6). The skin response also depends on extrinsic fac-
tors including radiation beam characteristics, dose fractionation 
schedule, affected volume, and surface area. In addition, many 
patients have concomitant disease that might enhance the effects 
of ionizing radiation (IR). Such conditions are diabetes mellitus, 
connective tissue diseases, radiosensitive genetic disorders such 
as ataxia telangiectasia, xeroderma pigmentosum, or Fanconi’s 
anemia, immunocompromised individuals, and obesity (6). 
Acute radiation-induced skin effects are always accompanied by a 
local inflammatory reaction. In the early stages of inflammation, 
there is triggering of pro-inflammatory cytokine production, 
which continues perpetually as a cascade during the whole pro-
cess of cutaneous reaction development (6, 9). Cytokines play a 
very important role in local and distant signaling and orchestrate 
the interaction between different cell types at tissue and organ 
level. There is evidence that the major cytokines involved in the 
response of skin cells to IR are IL-1β, IL-6, TNF-α, and TGF-β; 
furthermore, the prostaglandin PGE2 and the chemokines IL-8 
and eotaxin are involved (3, 4). Common for all the signaling 
molecules is their persistence in the cells and supernatants for 
24–48 h postirradiation (9, 10). This persistence causes long-term 
inflammatory reactions in skin after irradiation that can lead to 
late effect fibrosis.
The COX enzyme is responsible for the conversion of arachi-
donic acid to prostanoids, which are secondary signaling mole-
cules. It has two iso-forms: COX-1 that is constitutively expressed 
in the skin and cyclooxygenase 2 (COX-2) that is the inducible 
form produced after stimulation with cytokines and mitogens 
(11). COX-2 is known to be involved in the skin inflammation 
processes. It has also been found upregulated in conditions such 
as allergic asthma, rheumatoid arthritis, lipopolysaccharide- and 
TPA-induced skin inflammation, UVA- and UVB-induced ery-
thema, etc. (11, 12). Numerous non-steroid anti-inflammatory 
drugs such as celecoxib, nimezulid, rofecoxib, sulindac, and 
sc-236, all with different selectivity of COX-2 over COX-1 inhibi-
tion, have been developed in order to suppress the inflammatory 
effects. Despite the highly promising initial results, some of these 
inhibitors showed side effects such as gastroulceritis, dyspepsia, 
renal failure, even cardiac infarction, and several of the early 
drugs, e.g., rofecoxib have been withdrawn for patient treatment 
after the initial clinical trials. However, some of the more recent 
ones, such as celecoxib and sc-236, are still regarded as promising 
anti-inflammatory drugs (13, 14).
Nuclear factor kappa B (NF-κB) is a transcription factor that 
can bind the kappa immunoglobulin-light chain enhancer (15). 
The NF-κB protein family consists of five members (p65, c-Rel, 
RelB, NF-κB1, and NF-κB2). Two of these, NF-κB1 and NF-κB2, 
are initially synthesized as larger proteins, and later, they are 
proteolytically cleaved to smaller DNA-binding functional units 
(p50 and p52, respectively). The NF-κB proteins form homo- and 
heterodimers activated from different intra- and extracellular 
stimuli as DNA double-strand breaks (DSB), TNF-α, IL-1β, LPS, 
etc. (16, 17). NF-κB proteins are kept inactive in the cytoplasm 
by the inhibitory subunit of the IκB (inhibitor of κB) family. IκB 
are a family of six proteins IκB-alpha, -beta, -epsilon, -gamma, 
-zeta, and Bcl-3, which mask the nuclear localization signal of 
the NF-κB. Upon phosphorylation, the IκB are degraded and the 
NF-κB is released for nuclear translocation (18).
Nuclear factor kappa B is reported to have an important role 
in inflammation and cancer. When activated, from various pro-
inflammatory cytokines, NF-κB triggers the expression of genes 
responsible for cellular proliferation, antiapoptotic genes, and 
also has upregulatory function on angiogenesis. What is more, 
the transcription factor activation leads in turn to induction 
of cytokines responsible for immune reactions such as TNF-α, 
IL-1, IL-6, and IL-8, and also adhesion molecules which attract 
leukocytes to the sites of inflammation (15). Therefore, the dys-
regulation of this transcription factor is thought to be involved 
in various chronic inflammatory diseases, cancer development, 
and also in resistance to apoptosis-inducing cancer treatments 
(17). Interestingly, depending on the activating molecule, NF-κB 
could have either pro- or antiapoptotic effect (16). This specificity 
could be used in attempts to inhibit the NF-κB pathway in order 
to prevent cancer chemoresistance and to enhance the cancer 
cell killing at radiotherapy (19). The important role of NF-κB 
in the inflammation process makes this transcription factor a 
major target for treatment of chronic inflammatory diseases and 
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inflammation-associated tumors (17). COX-2 and NF-κB have 
been ascribed roles in both cancer development and radioresist-
ance of tumor cells (15, 20, 21). During radiotherapy, NF-κB is 
activated from DSB via the protein kinases ataxia telangiectasia 
mutated (ATM) and DNA-dependent protein kinase (DNA-PK) 
(15, 18). ATM is a serine kinase that senses DNA damage in 
the nucleus and, via different signal transduction pathways, 
regulates cell cycle, stress responses, and DNA repair (15). For 
example, patients with severe radiosensitivity, suffering from AT, 
have a defect in the ATM gene and additional NF-κB activation 
deficiency, which could be a reason for the enhanced apoptosis 
and severe responses to DNA-damaging agents (15). DNA-PK 
has a similar role in the DSB-mediated activation of NF-κB. 
In addition, the ROS generated during irradiation indirectly 
activate NF-κB via interactions with the allosteric regulators of 
the transcription factor (15). As a consequence, NF-κB has been 
attributed to a radioresistance-inducer role due to its antiapop-
totic function (21). The use of various selective NF-κB inhibitors 
(such as dexamethasone) was suggested to be able to potentiate 
the neutralization of cancer cells after radiotherapy (15, 16, 21). 
The role of NF-κB inhibitors as enhancers of radiotherapy has 
also been widely described in the literature (21, 22). Inhibition of 
the NF-κB pro-inflammatory function would also be beneficial 
for patients as it could increase normal tissue sparing (21).
3D organotypic tissue cultures have been widely used to study 
cell differentiation, intercellular signaling, and the influence of 
tumor suppressors and sensitivity to cell death of certain tissue 
cell types [reviewed in Ref. (23)]. The models have been used for 
studying the effects of different chemical agents on the skin (24) 
and also for testing how different gene mutations or infectious 
diseases affect epidermal differentiation, morphology, and bar-
rier function (25–27). Their spatial organization and functional 
properties make them suitable models for studying signaling 
processes in vitro. Thus, 3D skin cultures are a robust model for 
mechanistic studies on effects as radiodermatitis and testing of 
possible agents to reduce local inflammation and improve radio-
therapy outcomes.
In this project, we aimed to investigate the pro-inflammatory 
reactions triggered in stratified 3D organotypic skin models 
post exposure to clinically relevant radiation doses. We used 
partial lead shielding in order to examine the signal spread 
from exposed to non-exposed areas. We focused on two main 
inflammation controlling molecules NF-κB and COX-2 and the 
cytokines involved in the signaling under their control. Finally, 
we tested the impact of inhibition of NF-κB and COX-2 function 
on radiation response and how this could mitigate the spread of 
pro-inflammatory signaling to the surrounding tissue.
MaTerials anD MeThODs
cell culture
J2-3T3 mouse fibroblast cells were a kind gift from Prof. Dennis 
McCance laboratory (Queen’s University Belfast, Belfast, UK). 
They were cultured in 75  cm2 flasks at density 6.7 ×  103  cells/
cm2 in DMEM (MP Biomedicals, Illkirch, France) supplemented 
with 10% FCS (PAA, Pasching, Austria) and 1% penicillin/
streptomycin (PAA, Pasching, Austria), refed every third day and 
replated after reaching 80% confluency as assessed by microscope 
analysis.
N/TERT-1 normal human keratinocytes immortalized 
by transfection to express TERT (28, 29) obtained from Dr. 
Rheinwald from Harvard Institutes of Medicine, Boston, MA, 
USA, were grown in a medium commercially available from 
GIBCO, keratinocyte serum-free medium (K-sfm) (Invitrogen, 
Carlsbad, CA, USA). The medium has been supplemented as 
described in Ref. (29).
Organotypic raft cultures
Organotypic raft cultures were set up according to the method 
described in Ref. (23, 25) with modifications as described below. 
For clarity, we will further refer to the organotypic raft cultures 
also as “3D skin model,” “3D raft cultures,” and “3D organotypic 
model.” J2-3T3 fibroblast cells were treated with mitomycin 
C (Sigma-Aldrich, St. Louis, MO, USA) (4 µg/ml) to block the 
mitosis for a minimum of 2 h before using them for raft cultures. 
Fibroblasts were then trypsinised, spun down, and added to 
60–70% confluent N/TERT-1 keratinocytes in T25 flasks (~1:3 
fibroblast:keratinocytes ratio). J2-3T3 were added to keratino-
cytes in E-medium [formulation described in Ref. (30)] + EGF 
(Calbiochem, La Jolla, CA, USA) (10  ng/ml) and cocultured 
overnight. Before the keratinocytes were used in the 3D cultures, 
the fibroblasts were trypsinised from the cocultures by 2–3 min 
incubation with trypsin solution, followed by washing with PBS. 
In a separate step, collagen Type I plugs containing J2-3T3 feeder 
cells were prepared from 3  mg/ml final concentration Rat tail 
collagen (acidic) (BD, Bedford, MA, USA), 10× DMEM (MP 
Biomedicals, Illkirch, France), few drops of filter sterilized 1M 
NaOH to neutralize the acidic collagen. The final volume was 
2 ml per plug with a diameter of 23 mm. The collagen gels with 
added 4.5 × 105 J2-3T3 cells were let to solidify in hanging mem-
brane inserts (BD Falcon, NJ, USA) in 6-well plates. Once the 
gels have set, the 1 × 106N/TERT-1 keratinocytes per plug were 
plated on top and allowed to attach for 1 h. The cultures were fed 
with E-medium + EGF. On the next day, medium from the top 
chamber was aspirated, and the cultures were fed from the bot-
tom chamber with E-medium without EGF with the collagen gels 
at the air liquid interface to stimulate differentiation. The 3D skin 
cultures were fed daily for the first 2–3 days then every 2 days. The 
cultures were harvested at day 11, fixed in 4% paraformaldehyde 
for 1 h at room temperature, and processed for paraffin embed-
ding, sectioning at 6 µm thick sections for immunofluorescence 
and H&E staining.
irradiation experiments
Radiation exposures were performed using the XRAD 225 
(225  kVp X-ray) from Precision X-rays Inc. (N. Branford, CT, 
USA) at a dose rate of 0.591  Gy/min measured with a cali-
brated 0.6 cm3 waterproof Farmer Ionization Chamber with an 
UNIDOS E measuring device (PTW, Grantham, Lincolnshire, 
UK). The irradiation experiments with half shielding of the 3D 
cultures were performed using custom-designed frame and 2 cm 
thick low melting point lead-containing alloy MCP-96 blocks 
(Par Scientific, Odense, Denmark) positioned 2.05  cm above 
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the samples. The efficiency of shielding was confirmed by EBT3 
Gafchromic® film (Vertec Scientific Ltd., Reading, UK) measure-
ment with less than 2.3% of the dose delivered reaching under 
the shielded area and a sharp transition (dose falls from 90 to 
10% within 2 mm).
cOX-2 and nF-κB inhibitors  
Treatment of the 3D cultures
The COX-2 selective inhibitor sc-236 (Cayman Chemicals, Ann 
Arbor, MI, USA) was used to block the enzyme activity. The 
compound has IC50 of 10 nmol/l and approximately 18,000-fold 
COX-2 selectivity over COX-1, the other isoform of cyclooxyge-
nase. It was dissolved in DMSO at 20 mmol/l stock, and this stock 
solution was stored frozen at −20°C.
Bay 11-7085 (Sigma-Aldrich, Gillingham, Dorset, UK) is a 
specific irreversible inhibitor of TNF-α-mediated IκB phospho-
rylation with an IC50  ~  10  μmol/l. It was dissolved in DMSO 
at 20  mmol/l stock, and this stock solution was stored frozen 
at −20°C.
The N/TERT-1 keratinocytes and the 3D skin cultures were 
treated 1  h before irradiation. The inhibitors were kept in the 
culture medium for the whole duration of the experiment (up to 
7 days for the differentiation assay).
MTT assay
The method is based on the reduction of the yellow tetrazole 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) by the mitochondrial dehydrogenases to purple formazan 
dye. Briefly, 5,000 cells per well were plated in 200 µl of medium 
on a 96-well plate. The cells were allowed to attach overnight and 
treated with COX-2 or NF-κB inhibitor for 72 h. For each inhibitor 
concentration, there were six replicate wells. A total of 20 µl of the 
5 mg/ml tetrazolium MTT (Sigma-Aldrich, St. Louis, MO, USA) 
was added to each well and left for 3 h in an incubator at 37°C, 
5% CO2 allowing the cells to metabolize the dye. The medium 
was removed and the formed crystals of purple formazan were 
dissolved with 150 µl isopropanol (Sigma-Aldrich, St. Louis, MO, 
USA). The plates were wrapped in aluminum foil and agitated on 
a shaker for 20 min. Absorption of the purple MTT solution was 
measured at 570 nm with a BioTrak II plate reader (Amersham 
Biosciences, supplied from Vector Scientific, UK). Cell viability 
was calculated after subtracting absorption of isopropanol, which 
was used as a blank by normalizing to the untreated control.
qrT-Pcr
Total RNA was isolated from the 3D raft cultures using TRIzol™ 
reagent (Invitrogen, Carlsbad, CA, USA). The frozen 3D skin 
specimens were cut into small pieces (approximately 50–100 mg) 
while still frozen. The pieces were immediately placed into the 
TRIzol reagent for homogenization and vortexed at maximal 
speed for 60 s. The samples were incubated at RT for 5–10 min 
after homogenization.
Chloroform extraction and RNA precipitation were performed 
as described in the TRIzol™ reagent (Invitrogen, Carlsbad, CA, 
USA) manufacturer’s instructions. The RNA concentration was 
measured on a Nanodrop spectrophotometer ND-1000 (Mason 
Technology, Dublin, Ireland). Purity of the RNA was monitored 
by calculating the A260/280 ratio for protein contamination and 
A260/230—for polysaccharide contamination. The A260/280 in 
all experiments was >2. The integrity of the isolated from the 3D 
organotypic cultures RNA has been checked up by running on 
denaturing agarose gels in earlier experiments.
DNase I treatment and the reverse transcription with M-MLV 
(Moloney murine leukemia virus) reverse transcriptase were 
accomplished using reagents from Invitrogen (Carlsbad, CA, 
USA) according to the manufacturer’s protocol.
The polymerase chain reaction was performed using COX-2 
primers obtained from Qiagen (Mainz, Germany), assay number 
Hs_PTGS2_1_SG resulting in an amplicon length of 68 bp. The 
PCR efficiency was determined by calibration curves generated 
from serial dilutions of cDNA synthesized from non-treated 3D 
cultures (Figure S1 in Supplementary Material).
Each RT-PCR reaction contained 12.5 µl SYBR Green (Applied 
Biosystems, Carlsbad, CA, USA), 1 µl primer mix, 2.5 µl template, 
and 6.5 µl water. The RT-PCR reactions were run on DNA Engine 
Opticon 2 Real-Time Cycler (BioRad, Waltham, MA, USA). The 
following qRT-PCR protocol was used (1) one incubation step 
50°C for 2 min; (2) one incubation step 95°C for 5 min; and (3) 
40 cycles 95°C for 10 s; 60°C for 30 s; incubate 72°C for 5 min; 
melting curve 69–95°C; read every 0.2°C hold 1  s; 72°C for 
5  min. For every condition, three independent experiments in 
triplicates of each sample were performed. A standard curve was 
generated from serial dilutions of cDNA synthesized from non-
treated 3D cultures and used to manually set the threshold line to 
determine the threshold cycle (CT) values for COX-2 expression 
in the unknown samples. These results were normalized to the 
expression of the reference gene 18S rRNA in the same samples 
(Qiagen assay number Hs_RRN18S 1 SG; amplicon length 
149 bp). 18S rRNA has been previously used as a reference gene in 
larger scale organotypic culture gene expression studies (31). The 
normalization was performed using the 2−∆∆CT method according 
the BioRad Opticon 2 Real-Time Cycler user manual. First, we 
normalized the CT of the target gene to that of the reference (ref) 
gene, for both the test sample and the calibrator sample:
 ∆ =C C CT test T target test T ref test( ) ( , ) ( , )−  
 ∆ =C C CT calibrator T target  calibrator T ref  calibrator( ) ( , ) ( , )−  
After that, we normalized the ΔCT of the test sample to the 
ΔCT of the calibrator:
 ∆∆ = ∆ ∆C C CT T test T calibrator( ) ( )−  
Finally, we calculated the expression ratio:
 2 Normalized expression ratioT−∆∆ =C . 
In the formulas, CT are the threshold cycles and ΔCT is the 
difference in the CT values.
immunofluorescence staining  
of 3D Organotypic skin cultures
Culture sections were deparaffinized with xylene and decreasing 
alcohol concentrations. Following that, sections were subjected 
to antigen unmasking where required [i.e., filaggrin (FLG)] with 
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citrate buffer (20 min boiling, followed by 20 min on the bench). 
The slides were blocked in 10% FCS, 0.2% PBS-Triton X-100 for 
30  min, and incubated with primary antibodies in the follow-
ing dilutions: 1:50 for cytokeratin 1 (K1) (Vector Laboratories, 
Burlingame, CA, USA) and 1:100 for FLG (AnaSpec, San Jose, 
CA, USA). After overnight incubation with the primary antibody 
at room temperature, the sections were washed with 0.1% Triton 
X-100 in PBS and incubated with 1:1,500 secondary Alexa 488 
conjugated antibody (Molecular Probes, Invitrogen, OR, USA) 
for 1 h at room temperature. After washing with washing buffer, 
slides were counterstained with DAPI-containing mounting 
medium Vectashield (Vector Laboratories, Burlingame, CA, 
USA) and sealed with clean nail varnish.
Western Blotting
N/TERT-1 cultured in 2D or differentiated in 3D organotypic 
cultures (total cultures) were lysed with lysis buffer containing 
50 mM Tris, HCl pH 8.0, 150 mM NaCl, 1% Triton X-100, and 
protease and phosphatase inhibitor cocktail (Roche, Mannheim, 
Germany). The protein concentration was measured according 
to the Bradford method (BioRad, Munich, Germany). The pro-
tein solution was diluted in NuPage loading buffer (Invitrogen, 
Carlsbad, CA, USA) and 30 or 60 µg per line loaded on 4–12% Bis-
Tris NuPage precasted gels (Invitrogen, Carlsbad, CA, USA). The 
separated proteins were transferred on nitrocellulose membrane 
using iBlot semidry transfer apparatus (Invitrogen, Carlsbad, 
CA, USA). Membranes were blocked with blocking buffer [5% 
skimmed milk, 0.1% Tween 20 in PBS (PBS-T)] for 1 h at room 
temperature and incubated with primary antibody against 
COX-2 (Millipore, Temecula, CA, USA) 1:500;  phospho-p65Ser276; 
phospho-p38Tyr180/Tyr182 (Cell Signaling, Denver, MA, USA) 
1:1,000; GAPDH and β-actin 1:5,000 (Sigma-Aldrich, St. Louise, 
MO, USA) overnight at 4°C. The membranes were washed with 
0.1% PBS-T and incubated with secondary HRP-conjugated anti-
body (ECL™ anti-mouse/anti-rabbit IgG, GE Healthcare, Little 
Chalfont, UK) for 1 h at room temperature. After washing with 
0.1% PBS-T, membranes were incubated with SuperSignal ECL 
(Thermo Scientific, Rockford, IL, USA) and developed on X-ray 
sensitive film (GE Healthcare, Little Chalfont, UK).
Quantification of Differentiation  
Marker expression in 3D cultures
3D culture differentiation analysis was performed by quantifying 
the total expression of the differentiation marker proteins and by 
measuring the thickness variation of the cornified layers. Pictures 
were taken under the Carl Zeiss Axiovert 200M (Carl Zeiss, 
Göttingen, Germany) inverted fluorescence microscope with 
a 63× oil objective and CCD camera using Axiovision Rel. 4.6 
software, all from Carl Zeiss, Göttingen, Germany. The exposure 
parameters were kept constant, and the images were processed 
using Image J 1.04 (National Institutes of Health, Bethesda, MD, 
USA, http://imagej.nih.gov/ij/, 1997-2016) software. The percent-
age of K1 or FLG-positive area was quantified using thresholds 
set on the control images. The manual region of interest tool of 
Image J was used to determine the borders of the corresponding 
epidermal layer where the marker is expressed—granular layer 
(for FLG) or granular and suprabasal layer (for K1). Then, the 
intensity calculation option of the program was utilized to obtain 
the intensity per area values. The ratio between the treated and 
control samples intensity was used to represent graphically the 
expression. Results are mean from two independent experiments 
with two replicate slides per point and five visual fields with 
145 µm length per each slide.
enzyme-linked immunosorbent  
assay (elisa)
The medium samples were collected at time points 0, 24, 48, and 
72 h after irradiation of the 3D cultures. In part of the experi-
ments, the 3D skin was pretreated with sc-236 and Bay 11-7085 
at the concentrations described above. The inhibitors were added 
1 h before irradiation and were present in the culture medium 
for the whole duration of the experiment. The collected medium 
samples were centrifuged for 5 min at 3000 g to pellet any debris 
present that could affect the analysis and stored at −20°C.
For measuring the concentration of the PGE2 in the 3D cultures 
medium, an ELISA kit Parameter™ (R&D Systems, Abingdon, 
UK) was used according to the manufacturer’s instructions.
statistical analyses
Differences between groups were analyzed using a Student’s 
t-test or one-way ANOVA, Tukey posttest, part of the statistical 
package of GraphPad Prism version 6.00 for Windows, GraphPad 
Software, La Jolla, CA, USA, www.graphpad.com.
resUlTs
We analyzed the relative COX-2 expression in directly irradiated 
and shielded 3D skin cultures via qRT-PCR. The sham irradiated 
controls were collected together with the 24 h samples at the end 
of the experiment. The time points studied were chosen based on 
data from previous studies (32, 33).
The results from the qRT-PCR confirmed previously reported 
upregulation of the COX-2 gene that starts 2 h postirradiation and 
further increases at 4 h postirradiation (Figure 1). Interestingly, 
the shielded areas had an opposite downregulation of mRNA 
levels for the 2- and 4-h time points. This downregulation could 
not be explained by a simple delay in the gene response in the 
non-directly exposed bystander cells, because no increase had 
been observed at the later time points (24 h).
changes in radiation response after 
inhibition of cOX-2 signaling
After we observed significant COX-2 upregulation in the 3D skin 
model following localized irradiation, we tried to find ways to 
modify the radiation-induced responses of the model by altering 
the COX-2 expression and activity. For this purpose, we used 
sc-236, a well-described highly selective COX-2 inhibitor (20).
Before applying the inhibitor on the 3D cultures, its toxicity 
on N/TERT-1 cells was tested using the MTT assay as described 
in Section “Materials and Methods.” The results for 5, 10, 15, 
and 25  µmol/l concentrations of the inhibitor incubated with 
5,000 keratinocyte cells for 3  days indicated a statistically sig-
nificant increase in the toxicity for concentrations ≥10  µmol/l 
(Figure 2A).
FigUre 1 | comparison of cyclooxygenase-2 mrna expression in 3D 
organotypic cultures: control (cTrl), 2, 4, and 24 h after 2 gy 
irradiation, and 4 h after 2 gy irradiation plus 5 µmol/l sc-236 (n = 3). 
The CTRL samples, all non-irradiated, have been collected and analyzed at 
24 h after the irradiation of the test samples. Statistical analysis, one-way 
ANOVA Tukey posttest; **p < 0.01; ***p < 0.001; *p < 0.05.
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Accordingly from the results from the MTT assay and the data 
from the literature, we adopted 5 µmol/l as a working concen-
tration for studying the long-term radiation-induced effects in 
the 3D cultures. The cultures were pretreated for 1  h with the 
sc-236 and its effect on the COX-2 expression was measured at 
4 h postirradiation when the peak in COX-2 upregulation was 
observed (Figure 1).
At the 4 h time point, when in the directly irradiated samples, 
there was >2.5 times increase in the COX-2 mRNA levels, sc-236 
pre-treatment of samples led to a statistically significant down-
regulation of the COX-2 gene expression to less than 0.5 of the 
control levels (Figure 1). The COX-2 mRNA levels in the shielded 
areas did not change significantly after application of the sc-236 
inhibitor and were even slightly higher, than in the controls. This 
is probably due to the initial lack of activation of mRNA synthesis 
in the shielded areas (Figure 1) and the application of the inhibi-
tor not suppressing the basal COX-2 mRNA levels.
Morphology of the 3D cultures  
after sc-236 Treatment
Irradiation with the clinically relevant dose of 2 Gy changed the 
morphological structure of the 3D skin model increasing the 
thickness of the cornified layer (Figure  3). The expression of 
both early (Cytokeratin 1) and late (FLG) differentiation markers 
were modified as K1 was downregulated and FLG upregulated 
(Figures  3B–E). Following the experiments with the sc-236 
inhibitor and its effect on the pro-inflammatory COX-2 enzyme 
levels, a 5  µmol/l concentration was chosen to treat 3D skin 
cultures up to 7  days postirradiation to evaluate the effect on 
radiation-induced morphological changes (Figure 3).
Morphological analysis of the tissue sections treated with 
only sc-236 during the 7  days incubation period showed a 
normal tissue morphology, stratification, and thickness of the 
cornified layer. We compared the phenotype of half-shielded 3D 
cultures after the clinically relevant dose of 2 Gy radiation and 
half shielding with the same dose, but with addition of 5 µmol/l 
sc-236 treatment during the incubation period. The results were 
showing reduction of the hyperproliferation and formation of 
normal keratinized layer (Figure 3A).
In addition to the morphological analysis, we investigated 
the effects on stratification of the 3D model after the COX-2 
inhibitor treatment through following differentiation in the 
3D cultures and immunofluorescence of paraffin-embedded 
sections for expression of the early differentiation marker K1 
(Figures 3B,C). There was a slight upregulation in the K1 expres-
sion from 5 µmol/l sc-236 treatment, but the quantification of the 
expression showed that the effect was not statistically significant 
(Figures 3B,C). There was also rescue of the K1 expression in the 
2 Gy irradiated and sc-236 treated 3D cultures (Figures 3B,C) 
observed as statistically significant increases of the K1 levels in 
the shielded areas, essentially restoring them back to the control 
levels. Sc-236 showed the opposite effect on the expression of the 
late differentiation marker FLG (Figures 3D,E). The addition of 
the inhibitor suppressed the radiation-induced overexpression of 
FLG in both directly exposed and neighboring regions of the 3D 
cultures which was statistically significant for the 2 Gy exposed 
with and without inhibitor samples (Figure 3E).
radiation effects in Organotypic  
skin cultures after nF-κB inhibition
Nuclear factor kappa B is the major transcription factor that is 
responsible for the activation of COX-2 (16, 17). We measured 
the levels of the p65 NF-κB subunit that was phosphorylated on 
Ser276. First, we explored if irradiation of the 3D organotypic skin 
cultures induced phosphorylation and activation of p65 followed 
by its translocation into the nucleus. The immunofluorescence 
images showed translocation in the nucleus of p-p65 at 1 h postir-
radiation and still detectable 4 h after the broad field exposure of 
the cultures to 2 Gy 225 kVp X-rays (Figure 4A). However, this 
response was detected only in the irradiated parts of the 3D cul-
tures, with the neighboring areas showing less abundant nuclear 
translocation. The early effect in the irradiated cells suggests that 
NF-κB phosphorylation and nuclear translocation precedes the 
activation of COX-2.
Furthermore, we confirmed, via western blotting, the radia-
tion-induced phosphorylation of p65 in the skin samples 1 h post 
2 Gy irradiation (Figure 4B). We also tested the specific NF-κB 
inhibitor Bay 11-7085 to prevent the radiation-induced activation 
of the transcription factor (Figure  4B). The optimal non-toxic 
concentration of Bay 11-7085 was first tested on N/TERT-1 cells 
(Figure 2B). The Bay 11-7085 had higher toxicity than sc-236 as 
the application of the inhibitor at 5 µmol/l concentration led to 
a statistically significant reduction of cell viability (Figure 2B). 
Based on these data, we tested 1 µmol/l Bay 11-7085 on the 3D 
cultures for inhibition of p65 phosphorylation (Figure  4B). It 
was proven that Bay 11-7085 suppresses the p65 phosphoryla-
tion and also reduces the phosphorylation of p38 (Figure 4B), 
suggesting that there is a connection between the p-p65 forma-
tion and the p-p38 levels. NF-κB is one of the main transcription 
factors responsible for COX-2 upregulation in skin (34). After the 
observation that the p65 subunit of NF-κB is being phosphoryl-
ated and translocated into the nucleus 1  h postirradiation, the 
next step in our experiments was to determine if the addition of 
FigUre 2 | cytotoxicity testing of sc-236 cyclooxygenase-2 selective inhibitor (a) and Bay 11-7085 selective nF-κB inhibitor (B) via MTT assay 72 h 
after the treatment (n = 2). Error bars—SEM; statistical analysis—One-way ANOVA, Tukey posttest; *p < 0.05; **p < 0.01; ***p < 0.001.
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NF-κB inhibitor blocks the COX-2 activation. Western blots were 
performed to detect if the NF-κB inhibition influences COX-2 
expression (Figures 5A,B).
The addition of 1 µmol/l Bay 11-7085 to the culture medium of 
the 3D skin model induced complete disappearance of the p-p65 
4 h postirradiation (Figures 5A,C). The combination of the NF-κB 
inhibitor and 2 Gy irradiation did not have an effect on the p-p65 
levels, as these were upregulated 1 and 4 h postirradiation even 
at the highest concentration of the inhibitor used (Figures  4B 
and 5A,C). An important observation was the effect of 1 µmol/l 
Bay 11-7085 on the expression of COX-2. All the tested doses of 
NF-κB inhibitor downregulated the COX-2 expression after the 
2 Gy treatment (Figure 5B).
Morphology of the 3D cultures  
after Bay 11-7085 Treatment
In our studies, we also investigated morphological changes in 
the 3D cultures in the presence of 1 µmol/l Bay 11-7085 during 
the 7 days incubation period postirradiation. The inhibitor only 
treated cultures had both an increased density of the cornified 
layer and significant increase of the thickness of the cornified 
layer, but in general normal stratification (Figures  6A,D). The 
directly exposed regions had disrupted cornification, and there 
were numerous nuclei observed in the outer layers of the model 
(Figure 6A). In the half-shielded cultures irradiated with 2 Gy 
and treated with Bay 11-7085 H&E staining, there were also vis-
ible morphological changes. The NF-κB inhibition appeared to 
reduce the radiation-induced thickening of the cornified layer in 
both directly exposed and bystander areas of 3D skin cultures. 
Despite this positive effect, the overall morphology and thickness 
of Bay 11-7085 treated and irradiated 3D cultures showed large 
differences from the control (Figure 6A).
Additional to the H&E analysis, we also performed analysis 
and quantification of K1 and FLG expression in order to inves-
tigate the stages of the differentiation process in Bay 11-7085 
treated samples. First, K1 expression was evaluated. The inhibitor 
by itself led to a statistically significant reduction in the levels of 
K1 (Figures 6B,E) as quantification by Image J confirmed. The 
combination of 2  Gy IR and 1  µmol/l Bay 11-7085 treatment 
showed a statistically significant rescue of the K1 levels in the 
shielded areas of the cultures. However, the effect was not sig-
nificant in the directly irradiated parts. The increase in K1 levels 
in the inhibitor-treated samples was considerably lower than the 
control and not statistically different from the irradiated only 
samples (Figures 6B,E).
The effect of the Bay11-7085 on the morphology and expres-
sion of differentiation markers in the 3D cultures suggests that 
the inhibitor has a significant influence in changing the normal 
expression pattern of the early and late markers. In combination 
with IR, positive effects toward restoration of the normal tissue 
morphology were not observed and although there was partial 
rescue of the early differentiation marker K1, the complete reduc-
tion of FLG (Figures 6C,F) points to a substantial deviation from 
the normal differentiation pattern.
role of the Prostaglandin Pge2  
in skin radiation response
After observation of COX-2 upregulation in both directly 
irradiated and shielded areas of our 3D skin model and the 
inflammatory-like phenotype of the cultures, we further aimed to 
investigate if the PGE2 enzyme product of COX-2 is also upregu-
lated and the timescale of this process. Initially, we performed a 
PGE2 Parameter™ assay (R&D Systems, Abingdon, UK) on 3D 
culture medium samples collected 2, 4, 6, and 24 h postirradiation 
(data not shown). We could not detect any changes in the PGE2. 
In later experiments, a longer timescale was investigated. Samples 
were analyzed at 0, 24, 48, and 72 h postirradiation (Figure 7A).
Constant low basal levels of PGE2 were detected in all control 
samples during the time course of the experiment. In the 2 Gy 
irradiated samples, where we observed the highest COX-2 gene 
and protein induction at 4 h postirradiation and the most-signif-
icant morphological changes of the skin cultures, PGE2 induction 
was not detected before 72 h. However, at 72 h postirradiation, 
the COX-2 product’s levels were significantly elevated (6.5 times 
higher than in the initial levels of the non-irradiated 3D cultures 
medium).
FigUre 3 | rescue of the normal morphology of the 3D cultures after irradiation in the presence of 5 µmol/l specific cyclooxygenase-2 inhibitor 
sc-236 7 days postirradiation. (a) H&E staining; immunofluorescence staining of (B) cytokeratin 1 and filaggrin (D) as differentiation markers. Quantification of the 
differentiation maker expression by Image J as described in Section “Materials and Methods.” (c) and (e) Blue—DAPI; green—K1. Error bars—SEM; **p < 0.01; 
***p < 0.001, one-way ANOVA analysis, Tukey posttest.
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cOX-2 and nF-κB inhibition to control 
Prostaglandin levels
One of our main aims was to find possible strategies for reduc-
tion of the radiation-induced signaling within the 3D skin 
model that is responsible for the early and late effects. In this 
part of the experimental work, we aimed to investigate if the 
mechanism of reduction of the radiation-induced epidermal 
effects is based on decrease of the main product of COX-2, 
PGE2.
We tested if the PGE2 levels in the tissue culture medium were 
decreased after treatment of the cultures with 5  µmol/l sc-236 
specific COX-2 inhibitor 1 h prior to irradiation. A statistically 
significant increase in PGE2 levels was observed at 72 h postirra-
diation. The inhibitor reduced both the control levels of PGE2 in 
all samples and completely inhibited the prostaglandin synthesis 
by X-rays at 72 h (Figure 7B), suggesting that the prevention of 
the morphological changes in the 3D organotypic cultures postir-
radiation is mainly via suppression of PGE2 production.
FigUre 4 | nF-κB phospho-p65 formation 1–4 h after 2 gy irradiation of 3D skin model. Nuclear translocation 1–4 h postirradiation detected by 
immunofluorescence (a). Green—p-p65 stain. Western blot analysis 1 h postirradiation shows high levels of p-p38 in the irradiated samples (B). The addition of 
1 µmol/l Bay 11-7085 is suppressing the p-p65 formation (a,B). The graphs (B) represent the relative expression of p-p65 and p-p38 normalized to GAPDH 
detected by western blotting 1 h postirradiation. Results are arithmetical mean from two independent experiments. Each condition in these experiments had two 
replicate samples; error bars—SEM.
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DiscUssiOn
cOX-2 inhibitor and the control of 
radiation-induced reactions in the 3D 
skin Model: Possible applications of the 
cOX-2 inhibitor in radiotherapy
In order to find possible ways to control the inflammatory-like 
skin responses induced by IR, we used the COX-2 selective 
inhibitor sc-236 at concentrations that considerably reduced 
the COX-2 expression (Figures 1 and 3). The effects of sc-236 
were observed at transcriptional and translational level. After 
proving the inhibitory effect of sc-236, we aimed to reveal if 
its application would lead to suppression of the morphological 
changes that we observed in the irradiated and shielded 3D 
cultures. Experiments showed that COX-2 inhibition rescued 
the normal phenotype of the 3D cultures and hypercornifica-
tion was reduced (Figure 3). More importantly, expression of 
differentiation markers returned to levels comparable with the 
control (Figures  3B–E). Similar effects were observed in the 
shielded areas of the 3D cultures, suggesting that the blocking 
of COX-2 functions also reduces the signals toward the non-
irradiated areas and suppresses the bystander effects in the 3D 
skin model. The restoration of the expression levels of K1 and 
FigUre 5 | effect of Bay 11-7085 on cyclooxygenase-2 (cOX-2) and 
p-p65 expression 4 h postirradiation of 3D organotypic skin cultures. 
The 1 µmol/l treated samples show the effect of the inhibitor on the COX-2 
and p-p65 protein levels (a). The last three samples on each graph are 
increasing concentrations of the inhibitor plus 2 Gy 225 kVp X-ray irradiation. 
The positive irradiated control is 2 Gy. Graphs (B,c) represent the relative 
protein expression normalized to GAPDH. Results are arithmetical mean from 
two independent experiments. Each condition in these experiments had two 
replicate samples; error bars—SEM.
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the late marker FLG suggests formation of functional epidermis 
with preserved barrier functions and without late consequences 
of the exposure to the IR (27, 35, 36). There was FLG upregula-
tion from the inhibitor that could be explained with accelerated 
processing of the FLG precursor after COX-2 inhibition. COX-2 
has previously been reported to suppress FLG expression (37) 
and its inhibition might result in increased levels of FLG. 
However, studies with FLG overexpressing mice have shown 
that they do not have any defects in keratin folding, and the 
skin barrier function recovers more effectively after external 
insult (38).
All observations of COX-2 inhibitor effects in the 3D skin 
model imply that it could be used in the clinic for reduction of 
the normal skin effects after radiotherapy. Anti-inflammatory 
drugs, such as corticosteroids, have already been utilized in 
breast cancer treatment with a positive outcome for patients 
manifested as reduction of radiation-induced skin effects (7). 
One of the important functions of the COX-2 inhibitors is 
that they specifically target cells with increased COX-2 levels 
(14). COX-2 is induced in inflammatory tissue reactions, but 
it has also been reported to be upregulated in various tumor 
cell lines such as glioma, adenocarcinoma, and breast cancer 
(13, 14). According to these data, inhibition of COX-2 could 
increase the radiosensitivity of cancer cells. Consequently, the 
enzyme could be a suitable target during radiotherapy for both 
an increase in radiosensitivity of the tumor cells and a decrease 
of normal tissue reactions (39). Despite the expected positive 
effects, the majority of the COX-2 inhibitors have unexpected 
severe side effects (11, 13) and each one should be carefully 
tested before considering its clinical use. The sc-236 that has 
been used in our study showed low normal tissue cytotoxicity, 
has already been applied in preclinical studies as an anti-cancer 
treatment (20), and could be a promising anti-inflammatory 
drug in the treatment of radiation-induced skin inflammatory 
reactions.
nF-κB inhibitor and effect on the 
radiation-induced responses in  
the 3D Model
In a further attempt to reduce the skin model response to 
IR, we used an inhibitor of the transcription factor NF-κB 
(Figures 4–6). The role of NF-κB as a key element for radiation-
induced inflammation and its antiapoptotic function have been 
previously highlighted as potential targets for enhancement of 
the cell kill during radiotherapy treatments (16, 19, 22, 40). 
The p-Ser-276 modification of NF-κB is one of the major active 
forms of the transcription factor, induced from inflammatory 
stimuli such as TNF-α and LPS (16). NF-κB is activated by 
inflammatory cytokines and the process of signal transmission 
between the cytokine receptors and the intracellular transcrip-
tion factor is regulated via phosphorylation of p-p38 MAPK 
(17). On the basis of these data and studies showing direct 
activation of NF-κB by IR (19), we investigated the involvement 
of this transcription factor in the pro-inflammatory responses 
observed in the 3D skin model. To test its role, we decided to 
use a specific inhibitor NF-κB (Bay 11-7085) that prevents the 
phosphorylation of the p65 unit of the transcription factor. The 
inhibitor was not able to suppress completely the radiation-
induced p-p65 formation (Figure  4). The inhibitor has been 
found to downregulate COX-2 expression postirradiation 
(Figure 5). This was further evidence of the NF-κB → COX-2 
link for the series of reactions activated by radiation in skin. 
It has been suggested that the p38 MAPK is an intermediate 
player between these two molecules (40, 41) and in our studies 
the use of the NF-κB inhibitor reduced p-p38 phosphorylation 
(Figure  4B). It suggests also that Bay 11-7085 is not totally 
specific for suppressing p65 phosphorylation but also affects 
other targets. The phosphorylation of p38 might be switching 
on a cascade of phosphorylation reactions leading to long-term 
activation of NF-κB. However, if this is the connecting link 
or there is an intermediate transducer, it needs to be further 
confirmed.
Regarding the morphological effect, the use of the NF-κB 
inhibitor showed no evidence of being able to rescue the normal 
FigUre 6 | h&e staining—morphological analysis of the 3D cultures after irradiation and incubation of the 3D epidermal model with 1 µmol/l specific 
nF-κB inhibitor for a period of 7 days (a). Cytokeratin 1 (B) and filaggrin (FLG) (c) expression in 1 µmol/l Bay 11-7085 treated 3D organotypic skin cultures 
7 days after irradiation. Changes in the cornified layer thickness are calculated by Image J (D). Quantification of K1 and FLG expression in the same 3D cultures by 
Image J as described in Section “Materials and Methods” (e,F). Blue—DAPI; green—K1. Results are arithmetical mean from two independent experiments. 
*p < 0.05; **p < 0.01; ***p < 0.001, one-way ANOVA analysis, Tukey posttest.
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phenotype (Figure  6). On the contrary, the inhibitor had a 
detrimental effect on the 3D cultures similar to that induced by 
radiation. A possible explanation of these observations is that 
since NF-κB is an antiapoptotic factor, its inhibition causes an 
increase of both apoptotic death and development of harmful 
effects in normal tissue (22). The effects of the inhibitor on the 
expression of differentiation markers were also unfavorable. Bay 
11-7085 decreased K1 levels and up-regulated FLG (Figure 6). 
Similar effects were observed after radiation treatment only. The 
combination of radiation and NF-κB inhibition led to partial 
restoration of K1 in the directly irradiated areas and complete 
rescue of K1 levels in the shielded parts of the 3D cultures. 
FigUre 7 | Time dependence of Pge2 production in 3D organotypic skin cultures after 2 gy irradiation (a) and effect of cOX-2 inhibitor (5 µmol/l 
sc-236) on the secretion of Pge2 (B). The PGE-2 levels were measured at 0, 24, 48, and 72 h postirradiation. ***p < 0.001, one-way ANOVA analysis, Tukey 
posttest.
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Although there was a positive effect from the inhibitor on the 
expression of the early differentiation marker, the late marker 
FLG was drastically downregulated. This suggests abnormal 
differentiation, which possibly affects the normal functional 
properties of the 3D skin cultures (35). Since the inhibition of 
COX-2 had a restoring effect on the 3D culture morphology and 
differentiation and the NF-κB inhibition reduces COX-2 expres-
sion, it could be expected that NF-κB inhibition also would 
have a positive effect on the in vitro skin model postirradiation. 
Interestingly, we did not observe such rescue, but the opposite—
negative effects on the 3D culture development in the presence 
of inhibitor. This could be explained by the crucial role of NF-κB 
in important epidermal processes such as cellular growth and 
homeostasis, epidermal proliferation, and differentiation (34). 
NF-κB p65 nuclear translocation has been highlighted as an 
important factor in the exit of the basal cells from the cell cycle 
that pushes them toward terminal differentiation (42). The 
same authors suggested that NF-κB inhibition could induce 
epidermal hyperplasia by blocking this mechanism of basal cell 
cycle exit. This could be the reason for the increased thickness of 
the cornified layer in Bay 11-7085 treated cultures. Even though 
NF-κB inhibition is thought to have an anti-inflammatory effect, 
in combination with its hyperproliferation inducing capacity 
in skin, the overall effect for the tissue response tends to be 
negative.
role of Pge2 Prostaglandin in radiation-
induced responses in 3D skin Model
The inflammatory-like cascade triggered by IR in 3D skin includes 
long distance-acting signaling molecules. We focused our atten-
tion on the PGE2 prostaglandin produced by COX-2 since it has 
important role in the perpetuation and maintenance of the local 
inflammation (10, 34).
PGE2 upregulation was observed considerably later than the 
irradiation of the 3D cultures (Figure 7). The prostaglandin pro-
duction was detectable and statistically significant over control 
levels at 72  h after exposure. This suggests that COX-2 and its 
product PGE2 are more likely to make a strong contribution 
to the persistence of the pro-inflammatory changes of the 3D 
epidermal model, rather than at the early stage of signal transduc-
tion. Moreover, COX-2 has previously been described to play an 
important role in the completion of the differentiation process 
and mice with overexpression of COX-2 have been shown to 
develop abnormally differentiated epidermis (43). Here, we note 
that the basal levels of PGE2 postirradiation or after the inhibitor 
treatments has been very low, below control levels. The reason for 
this is not clear and further work is required. Furthermore, we 
investigated if the inhibition of COX-2 has a substantial effect on 
the release of PGE2 (Figure 7). When using the sc-236 inhibitor, 
a total reduction of radiation-induced PGE2 production at 72 h 
postirradiation was observed. This observation and the rescue 
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of the normal phenotype and differentiation pattern of the 3D 
skin model support the hypothesis that the COX-2 enzyme via 
its product PGE2 is responsible for the late radiation-induced 
reactions in the 3D organotypic skin cultures.
The model used in these experiments has many advantages 
including its ability to differentiate and produce cytokines and 
prostaglandins upon pro-inflammatory stimuli. Although an 
interspecies model, it has reliable and reproducible differentia-
tion abilities that have been used in our experiments. However, 
it should be kept in mind that this system also has limitations, 
especially when considering immune responses. Further experi-
ments with more complicated models, involving an immune cell 
compartment are needed to extend the knowledge in these areas.
In conclusion, the use of inhibitors for reduction of side effects 
of radiation and the potential application in radiotherapy should 
be approached with caution. From the two anti-inflammatory 
inhibitors that have been tested, the COX-2 inhibitor seems 
a good candidate for the reduction of normal tissue effects, 
without affecting tissue differentiation and morphology. The 
NF-κB inhibitor on the other hand, despite reducing some of 
the radiation-induced morphological features (especially in the 
bystander areas), had a detrimental effect on differentiation 
markers expression and possibly on the 3D skin culture barrier 
function.
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